MEK2 Antibody Blocking peptide
MEK2 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Dual specificity mitogen-activated protein kinase kinase 2, MAP kinase kinase 2, MAPKK 2, ERK activator kinase 2, MAPK/ERK kinase 2, MEK 2, MAP2K2, MEK2, MKK2, PRKMK2
UniProt
P36507
Field of Research
Signal Transduction
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1928777 was selected from the N-term region of human MEK2 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC1006424-01 25 mg
(S) -6- (3-Cyclopentyl-2- (4- (trifluoromethyl) -1H-imidazol-1-yl) propanamido) nicotinic acid
Sign In for Pricing
View Details PC1006424-02 50 mg
(S) -6- (3-Cyclopentyl-2- (4- (trifluoromethyl) -1H-imidazol-1-yl) propanamido) nicotinic acid
Sign In for Pricing
View Details PC1006424-03 100 mg
(S) -6- (3-Cyclopentyl-2- (4- (trifluoromethyl) -1H-imidazol-1-yl) propanamido) nicotinic acid
Sign In for Pricing
View Details PC1006424-04 250 mg
(S) -6- (3-Cyclopentyl-2- (4- (trifluoromethyl) -1H-imidazol-1-yl) propanamido) nicotinic acid
Sign In for Pricing
View Details